SCHEMBL15529434

SCHEMBL15529434

COCCOCC(=O)N1CCC(Oc2ccc(NC(=O)N3CC(c4cccnc4)C3)cc2)C1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15529429 1.00 NAMPT (0.61) NAMPT
SCHEMBL15528725 0.94 NAMPT (0.53) NAMPT
SCHEMBL15528885 0.93 NAMPT (0.70) NAMPT
SCHEMBL15528888 0.93 NAMPT (0.70) NAMPT
SCHEMBL15529746 0.91 NAMPT (0.71) NAMPT
SCHEMBL15529749 0.91 NAMPT (0.71) NAMPT
SCHEMBL15529447 0.89 NAMPT (0.68) NAMPT
SCHEMBL15529102 0.88 NAMPT (0.68) NAMPT
SCHEMBL15529110 0.88 NAMPT (0.73) NAMPT
SCHEMBL15529766 0.88 NAMPT (0.58) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2852585-A1 NAMPT INHIBITORS AbbVie Inc. (US) 2015-04-01 EP claimed
WO-2013170113-A1 NAMPT INHIBITORS ABBVIE INC. (US) 2013-11-14 WO claimed
EP-2852585-A1 NAMPT INHIBITORS AbbVie Inc. (US) 2015-04-01 EP disclosed
WO-2013170113-A1 NAMPT INHIBITORS ABBVIE INC. (US) 2013-11-14 WO disclosed